公司概覽
業務類別 Medical Devices
業務概覽 One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
公司地址 Parkmore Business Park West, Building Two, Galway, IRL
電話號碼 +353 14381700
傳真號碼 --
公司網頁 https://www.medtronic.com
員工數量 95000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Geoffrey S. Martha Chief Executive Officer and Chairman of the Board 美元 1.35M 18/06/2026
Mr. Skip Harry Kiil Executive Vice President and President, Cardiovascular Portfolio -- 18/06/2026
Ms. Que Thanh Dallara Chief Executive Officer, New Diabetes -- 21/05/2025
Ms. Michelle Quinn Executive Vice President, General Counsel and Secretary -- 18/06/2026
Mr. Michael Marinaro Executive Vice President and President, Medical Surgical Portfolio , Americas, and Global Commercial Operations -- 18/06/2026
Mr. Matthew R. Walter Senior Vice President, Human Resources, IT, and Global Communications and Corporate Marketing -- 18/06/2026
Mr. Thierry Pieton Chief Financial Officer and Executive Vice President 美元 884.65K 18/06/2026
Ms. Denise L. Blomquist Vice President, Global Controller and Chief Accounting Officer -- 18/06/2026
Mr. Michael Carter Senior Vice President and President, Cranial and spinal-Technologies business -- 21/05/2025
Dr. Kweli Thompson Executive Vice President and President, Neuroscience Portfolio -- 18/05/2026
 
董事會成員
董事會 職務 更新日期
Mr. Craig Arnold Lead Independent Director 18/06/2026
Mr. Kendall J. Powell Independent Director 18/06/2026
Ms. Lidia L. Fonseca Independent Director 18/06/2026
Mr. Randall J. Hogan, III Independent Director 18/06/2026
Mr. William R. Jellison Independent Director 18/06/2026
Mr. Scott C. Donnelly Independent Director 18/06/2026
Mr. Kevin E. Lofton Independent Director 18/06/2026
Mr. Geoffrey S. Martha Chief Executive Officer and Chairman of the Board 18/06/2026
Mr. John P. Groetelaars Independent Director 18/06/2026
Dr. Elizabeth G. Nabel, M.D. Independent Director 18/06/2026
Mr. Gregory P. Lewis Independent Director 18/06/2026
Dr. Joon Lee, M.D. Independent Director 18/06/2026
 
所屬ETF (更新日期: 25/07/2026 03:24)
代號 名稱 佔比% 持有日期
IVViShares Core S&P 500 ETF1.38%30/06/2026
SPYState Street® SPDR® S&P 500® ETF1.21%30/06/2026
XLVState Street®HlthCrSelSectSPDR®ETF0.71%30/06/2026
VIGVanguard Dividend Appreciation ETF0.57%30/06/2026
CGDVCapital Group Dividend Value ETF0.41%30/06/2026
VYMVanguard High Dividend Yield ETF0.40%30/06/2026
DGROiShares Core Dividend Growth ETF0.32%30/06/2026
VHTVanguard Health Care ETF0.30%30/06/2026
SDYState Street® SPDR® S&P® Dividend ETF0.28%30/06/2026
JEPIJPMorgan Equity Premium Income ETF0.26%30/06/2026
SPYMState Street® SPDR® Port S&P 500® ETF0.24%30/06/2026
HDViShares Core High Dividend ETF0.23%30/06/2026
IWDiShares Russell 1000 Value ETF0.22%30/06/2026
RSPInvesco S&P 500® Equal Weight ETF0.18%30/06/2026
FDLFirst Trust Morningstar Div Leaders ETF0.17%30/06/2026
IVEiShares S&P 500 Value ETF0.17%30/06/2026
NOBLProShares S&P 500 Dividend Aristocrats0.15%30/06/2026
IHIiShares US Medical Devices ETF0.13%30/06/2026
ITOTiShares Core S&P Total US Stock Mkt ETF0.13%30/06/2026
SPYVState Street SPDR Port S&P 500 Val ETF0.12%30/06/2026
 1    2    3    4    5    6    7    8    9    10    11    12    13    14    15    16    17    18    19    20    21    22    23    24  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.